矩阵刚度对肝细胞功能,肝纤维化和肝细胞癌的影响 - 基于定量数据
Kiyoon Min1, Sathish Kumar Karuppannan1, Giyoong Tae1
1School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Biophysics reviews
|June 7, 2024
概括
矩阵度显著影响肝脏健康. 更软的支架支持健康的肝细胞功能,而更硬的支架则促进纤维化和肝细胞癌 (HCC) 的进展.
科学领域:
- 生物材料科学 生物材料科学
- 肝病学 肝病学是一种肝病学.
- 组织工程是组织工程.
背景情况:
- 开发体外肝细胞培养模型对于疾病建模和药物查至关重要.
- 使用支持性支架模仿体内肝脏微环境对于准确的研究至关重要.
- 本综述侧重于跨疾病阶段的肝细胞培养中的矩阵刚性.
研究的目的:
- 提供使用生物支架的肝细胞培养的全面审查.
- 分析矩阵刚度对肝脏健康,纤维化和肝细胞癌 (HCC) 的影响.
- 为提升肝脏组织工程中的支架发展提供洞察力.
主要方法:
- 对肝细胞培养和矩阵刚度的现有文献的审查.
- 分析肝脏的生理和功能方面.
- 探索肝细胞行为,以应对不同的矩阵刚度.
主要成果:
- 更软的矩阵增强肝细胞的增殖,迁移和功能.
- 更硬的矩阵促进肝星细胞的激活,有助于纤维化.
- 升高的矩阵刚度与增加的HCC扩散,转移和耐药性相关.
结论:
- 矩阵刚度是肝细胞行为和疾病进展的关键因素.
- 脚手架设计必须考虑矩阵刚性,以获得有效的肝组织工程.
- 需要进一步的研究来优化生物支架用于肝病建模和治疗.
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...